Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Jason A. Sprowl(University at Buffalo, State University of New York), Alex Sparreboom(The Ohio State University), Hugh Giovinazzo(Sidney Kimmel Comprehensive Cancer Center), Alice A. Gibson(The Ohio State University), Anthony F. Shields(Wayne State University), Guoqing Du(Inner Mongolia University), Guido Cavaletti(Bellvitge University Hospital), Giuliano Ciarimboli(University Hospital Münster), Laura J. Janke(St. Jude Children's Research Hospital), Cynthia S. Lancaster(St. Jude Children's Research Hospital)
Cited by 175
Related Papers
Cremophor EL
|European Journal of Cancer|2001|1.6k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Recommendations on the Use of <sup>18</sup>F-FDG PET in Oncology
|Journal of Nuclear Medicine|2008|1.1k
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884